Pharmaron Beijing Co., Ltd. (SHE:300759)
China
· Delayed Price · Currency is CNY 30.19
-0.65 (-2.11%)
Aug 14, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Laboratory Services | 7.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Services Growth | 5.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chemical and Formulation Process Development and Production Services | 2.99B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chemical and Formulation Process Development and Production Services Growth | 10.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Research Services | 1.83B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Research Services Growth | 5.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Macromolecule and Cell and Gene Therapy Services | 407.52M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Macromolecule and Cell and Gene Therapy Services Growth | -4.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 6.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 38.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 6.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 38.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Other | 39.51M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -19.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | 7.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | 6.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 2.27B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 23.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 1.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -6.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 264.27M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | -1.77% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 39.51M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -19.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|